Colin Pritchard does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Investigators believe the SWIFT-seq system holds potential to replace more invasive bone marrow biopsies. The SWIFT-seq method, which employs single-cell sequencing to profile circulating tumor cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback